CUBT vs AMGN: Which Stock is Better?

Side-by-side comparison of Curative Biotechnology Inc and Amgen Inc in 2026

Comparison Updated:

CUBT

Curative Biotechnology Inc

$0.01

AMGN

Amgen Inc

$331.00

Key Metrics Comparison

MetricCUBTAMGNWinner
Market Cap$6.54M$178.24BAMGN
P/E RatioN/A25.58AMGN
EPS (TTM)$N/A$12.94AMGN
Revenue Growth0.0%0.1%AMGN
Gross Margin75.7%70.1%CUBT

Analyze CUBT

Full quant analysis

Analyze AMGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is CUBT or AMGN a better investment?

Comparing CUBT and AMGN: Curative Biotechnology Inc has a market cap of $6.54M while Amgen Inc has $178.24B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between CUBT and AMGN?

CUBT (Curative Biotechnology Inc) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: CUBT or AMGN?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: CUBT or AMGN?

AMGN has higher revenue growth at 0.1% vs 0.0% for CUBT.

Which company is more profitable: CUBT or AMGN?

Curative Biotechnology Inc (CUBT) has higher gross margins at 75.7% compared to 70.1% for AMGN.

Which is the larger company: CUBT or AMGN?

Amgen Inc (AMGN) is larger with a market cap of $178.24B compared to $6.54M for CUBT.

Should I buy CUBT or AMGN in 2026?

Both CUBT and AMGN have investment merit. CUBT trades at $0.01 while AMGN trades at $331.00. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between CUBT and AMGN stock?

Key differences: Market Cap ($6.54M vs $178.24B), P/E Ratio (N/A vs 25.6x), Revenue Growth (0.0% vs 0.1%), Gross Margin (75.7% vs 70.1%).

Popular Stock Comparisons